QualityStocksNewsBreaks Archives - Page 664 of 1527

ThursdaySep 30, 2021 1:35 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Begins Phase 2 Clinical Trial Evaluating CBN in the EB Treatment

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has started its Phase 2 clinical trial of INM-755 (cannabinol) cream in the treatment of epidermolysis bullosa (“EB”). According to the company, this is the first time cannabinol has advanced to a Phase 2 clinical trial to be studied as a therapeutic option to treat a disease. The study will be conducted in seven different countries at 11 sites; the countries include Austria, Germany, Greece, France, Italy, Israel and Serbia. The company has filed clinical trial applications in all seven countries and has received approval from…

ThursdaySep 30, 2021 1:22 pm

QualityStocksNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Making Strategic Investments to Tap into Hyper-Growth Opportunities

AmpliTech Group (NASDAQ: AMPG), a company with a rich history in the design and manufacture of microwave amplifiers and components, has always focused on building a strong reputation anchored on performance and quality. This focus has earned it follow-on orders for its Low Noise Amplifier (“LNA”) technology from several global customers, including a high-speed satellite broadband services provider and a Fortune 500 defense and aerospace customer. AmpliTech has also gained recognition through receipt of numerous supplier quality awards, including one for best technology from an industry leading trade magazine. The company anticipates growing business activity and increased customer demand as…

ThursdaySep 30, 2021 1:12 pm

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Enters First-of-Its-Kind Partnership with Paradigm Healthcare

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), the leading psychedelic wellness platform, has announced a first-of-its-kind partnership with Paradigm Healthcare, an independent clinical laboratory located in St. Simons, Georgia, with a focus on high complexity, clinical toxicology, to bring state-of-the-art testing to Ketamine Infusion Centers LLC (“KIC”). Under the partnership, KIC will have access to Paradigm’s Benchmark UDT(TM) toxicology solution that utilizes LC/MS/MS test methods to identify and accurately measure drug compounds in the body, ensuring the highest quality toxicology results and clinically relevant test data to support medical decision making. “Paradigm’s Benchmark testing platform brings state-of-the-art drug testing…

ThursdaySep 30, 2021 1:04 pm

QualityStocksNewsBreaks – Save Foods Inc.’s (NASDAQ: SVFD) Proprietary Technology Designed to Deliver Freshness and Quality, Field to Fork

Save Foods (NASDAQ: SVFD) is dedicated to delivering integrated solutions for improved safety, freshness and quality every step of the way from field to fork. Speaking as a guest on the latest episode of The Stock2Me Podcase, newly appointed board chairman Dr. Art Dawson noted that Save Foods has successfully completed the development and has also begun to market natural, eco-friendly treatment for fresh produce. These solutions are used in the process of protecting fresh fruits and vegetables, and, therefore, they're an important part of the economic scheme of the fresh produce value chain. Save Foods' solution not only prolongs…

ThursdaySep 30, 2021 12:50 pm

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) Exceeds Milestones to Trigger Bonus $1.7M in Bitmain Miners

ISW Holdings (OTC: ISWH) (transitioning to “BlockQuarry,” pending name change), a Nevada-based portfolio company with primary commercial-stage operations in cryptocurrency mining, today announced that it has surpassed agreed-upon milestones related to the performance of its common stock price. The company will, therefore, receive an additional 150 Bitmain S19 95TH/s miners from Minerset, a Delaware LLC, due to negotiated milestone clauses included in the asset purchase agreement reached between the two companies in August. According to the update, the company leveraged its shares of Preferred B stock to purchase its initial tranche of 400 miners. As a part of the contract, ISW…

ThursdaySep 30, 2021 12:40 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Simplifying Patients’ Lives with Easy Access to Point-of-Care Testing

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has remained committed to becoming the world’s largest health data company, as evidenced by its move to innovate and leverage specific point-of-care technologies within its community of pharmacies. It has also partnered with Abbott Canada, Shoppers Drug Mart and Ellerca Health in a bid to facilitate its growth and make its technology and services accessible to as many people as possible. “Avricore’s flagship platform, HealthTab(TM), impacts the healthcare sector mainly by simplifying patients’ lives with easy access to point-of-care testing,” reads a recent article. “With HealthTab, Avricore can offer pharmacies complete turnkey and point-of-care…

ThursdaySep 30, 2021 12:05 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Offers Innovative, Practical Solution for Green Hydrogen

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is making the green hydrogen economy possible through its proprietary carbon-free ammonia (“NH3”) system. “The hydrogen economy envisions a future where carbon-free hydrogen is used for energy storage, long-distance transportation of energy, and as a fuel for vehicles and heat generation,” reads a recent article. Although hydrogen, as a fuel, burns cleanly and produces more power per unit weight than gasoline, diesel or even lithium-ion batteries, there are practical problems that have so far prevented the implementation of the hydrogen economy. Firstly, blue and grey hydrogen production using the traditional methods is energy intensive and…

ThursdaySep 30, 2021 11:57 am

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Commences Trading on the OTCQX Best Market

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research in psychedelics, today announced that it has graduated from the OTCQB Venture Market to now trade on the OTCQX Best Market, the highest tier of OTC Markets Group. “Receiving approval to trade on the OTCQX is an important milestone for MINDCURE, validating the outstanding efforts of our entire team to build a leading psychedelics company and to drive value for patients, therapists, clinics and shareholders,” said Kelsey Ramsden, president and chief executive officer of MINDCURE. “Trading on the OTCQX Market enhances the…

ThursdaySep 30, 2021 11:36 am

QualityStocksNewsBreaks – DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Releases Q2 2022 Financial Results, Corporate Update

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, is reporting its financial results for both the three-month and six-month period ended on July 31, 2021. Worth noting is the announcement that the company saw unrealized gain on digital currencies for the period of C$2.65 million while net equity in the company reached C$17.39 million in Q1 2022 and a further C$1.9 million in Q2 2022. Since unrealized digital currency gains are not included in the net income/loss report under IFRS but are recognized under comprehensive loss, revenues for the six months ended…

ThursdaySep 30, 2021 10:23 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Doses First Group of Patients in Potentially Pivotal Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced the dosing of the first patients in its Berubicin clinical development program for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. According to the update, further patient enrollment, randomization and dosing is currently underway as well as a robust lineup of globally located clinical sites, which are advancing toward activation and enrollment. “As one of the most aggressive, deadly and treatment-resistant cancers that…

Site Search

Company Search

Category: QualityStocksNewsBreaks